Flurbiprofen Axetil

CAS No. 91503-79-6

Flurbiprofen Axetil ( Flurbiprofen Axetil; Ropion; Lipfen; LFP-83 )

Catalog No. M19255 CAS No. 91503-79-6

Flurbiprofen Axetil is an anti-inflammatory used as an analgesic.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 31 In Stock
10MG 50 In Stock
25MG 87 In Stock
50MG 147 In Stock
100MG 230 In Stock
200MG 340 In Stock
500MG 565 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Flurbiprofen Axetil
  • Note
    Research use only, not for human use.
  • Brief Description
    Flurbiprofen Axetil is an anti-inflammatory used as an analgesic.
  • Description
    Flurbiprofen Axetil, also known as Ropion, is a prodrug of Flurbiprofen that provides better analgesia effects and few side effects.
  • Synonyms
    Flurbiprofen Axetil; Ropion; Lipfen; LFP-83
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    COX-1; COX-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    91503-79-6
  • Formula Weight
    330.36
  • Molecular Formula
    C19H19FO4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    c1(c(cc(cc1)C(C(=O)OC(C)OC(=O)C)C)F)c1ccccc1
  • Chemical Name
    1-Acetyloxyethyl 2-(3-fluoro-4-phenylphenyl)propanoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kathleen MK, et al. Defining the COX Inhibitor Selectivity of NSAIDs: Implications for Understanding Toxicity. Expert Rev Clin Pharmacol. 2010;3(6):769-776.
molnova catalog
related products
  • Cerebellin

    Cerebellin is a 16-amino acid peptide, originally isolated from rat cerebellum, whose presence has been recently demonstrated in the human adrenal glands and especially in medullary chromaffin cells.

  • Ulixertinib

    Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.

  • Parimifasor

    Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).